Cite

MLA Citation

    Nicolás Fissolo et al.. “Serum Neurofilament Levels and PML Risk in Patients With Multiple Sclerosis Treated With Natalizumab.” Neurology, vol. 8, no. 4, 2021, p. . http://access.bl.uk/ark:/81055/vdc_100142319755.0x000007
  
Back to record